Central Ayurveda Research Institute Excipients PVP K30 & Silicon Dioxide Tender Jhansi Uttar Pradesh 2026

Tender Overview

Central Council for Research in Ayurvedic Sciences under the Central Ayurveda Research Institute invites bids for excipients comprising PVP K30 and Silicon Dioxide in Jhansi, Uttar Pradesh. The procurement scope covers two key chemical excipients required for Ayurvedic formulations, with no BOQ items listed. The contract includes an option clause allowing up to 25% quantity variation both at the initial award and during contract execution, at the same contracted rates. Delivery timing is linked to the last date of the original delivery order; additional time follows a calculated formula, with a minimum extension of 30 days. The tender emphasizes supplier readiness to accommodate variable quantities within the stated threshold.

• Organization: Central Ayurveda Research Institute, under CCRAS
• Location: Jhansi, Uttar Pradesh 284001
• Product category: Excipients (PVP K30, Silicon Dioxide)
• Estimated value/EMD: Not specified
• Unique clause: 25% quantity variation with proportionate delivery extension; extension period governed by the formula (Increased quantity ÷ Original quantity) × Original delivery period

Technical Specifications & Requirements

• Product names: PVP K30 and Silicon Dioxide (excipient grade)
• Quantity scope: Flexible up to 25% increase/decrease from bid quantity; delivery period adjustments as per option clause
• Delivery basis: From the last date of the original delivery order; additional time rules apply
• Standards/quality: Not specified in BOQ; supplier must align with typical pharmaceutical excipient standards and any CCRAS/ISG GMP expectations if stated in ATC
• OEM/brand: Not specified; no explicit brand requirement in available data
• Technical documentation: Not provided; bidders should be prepared to supply standard excipient certificates, if requested

Terms, Conditions & Eligibility

• Option clause: Purchaser may change quantity ±25% during contract; calculated delivery extension uses (Increased quantity ÷ Original quantity) × Original delivery period, minimum 30 days
• Delivery timeline: Based on original delivery period; extended period aligns with option clause rules
• Payment/penalties: Not specified in available data
• EMD/financials: Not specified in available data
• Documents: Not enumerated in the provided terms; bidders should anticipate standard compliance documents for excipient purchases
• Eligibility: Not specified; bidders should prepare to demonstrate capability for pharmaceutical excipients and regulatory adherence